Spectrum Pharmaceuticals (NasdaqGS: SPPI), a biotechnology company with
fully integrated commercial and drug development operations with a
primary focus in hematology and oncology, today announced key
presentations of clinical and scientific data related to its products at
the 56th Annual Meeting of the American Society of Hematology (ASH),
being held in San Francisco, California, from December 6-9, 2014.
for Spectrum Pharmaceuticals Highlights 11 Abstracts at the 56th Annual Meeting of the American Society of Hematology (ASH) in San Francisco, California, December 6-9, 2014 investment picks